血液透析血管通路的新器械与技术综述
该综述总结了血液透析血管通路领域的新器械与技术进展,包括用于建立动静脉内瘘的新型血管内装置、生物工程移植物、药物涂层球囊和覆膜支架等,这些创新有望减少中心静脉导管依赖并改善通路结局。
要点
- 血管内装置建立动静脉内瘘可能克服永久性通路建立的障碍
- 生物工程移植物早期研究有前景,仍需与合成或冷冻保存选项比较
- 药物涂层球囊和覆膜支架可能辅助延长通路通畅性
核心结论
- 血液透析血管通路领域的器械与技术进展可能在未来改变临床实践模式。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- 在美国,血液透析仍是肾衰竭最常见治疗方式,近90%的新发患者选择该治疗。
- 新型血管内装置建立动静脉内瘘可能解决启动维持性血液透析时永久通路建立的障碍。
- 在 prevalent 血液透析人群中,微创血管内动静脉内瘘手术应有助于改善通路建立的长等待时间。
- 生物工程移植物正在开发中,可能为聚四氟乙烯移植物提供另一种选择。
- 药物涂层球囊和覆膜支架等器械的适当使用可能补充动静脉通路建立的新技术。
临床怎么用
- 临床可关注血管内动静脉内瘘建立技术以减少中心静脉导管依赖。
- 生物工程移植物可能作为聚四氟乙烯移植物的替代选项,需待进一步临床结局比较。
- 药物涂层球囊和覆膜支架可用于延长血管通路通畅性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the United States, hemodialysis remains the most common treatment modality for kidney failure, chosen by almost 90% of incident patients. A functioning vascular access is key to providing adequate hemodialysis therapy. Recently, major innovations in devices and technology for hemodialysis vascular access care have rapidly changed the landscape. Novel endovascular devices for creation of arteriovenous fistulas may offer a solution to the barriers encountered in initiating maintenance hemodialysis with a permanent vascular access rather than a central venous catheter (CVC). Furthermore, in the prevalent hemodialysis population, the minimally invasive endovascular arteriovenous fistula procedure should help improve long wait times for vascular access creation, which remains a major barrier to reducing CVC dependence. Bioengineered grafts are being developed and may offer another option to polytetrafluoroethylene grafts. Early studies with these biocompatible grafts are promising, as additional studies continue to evaluate their clinical outcomes in comparison to cryopreserved or synthetic options. Prolonging the vascular access patency with appropriate use of devices such as drug-coated balloons and stent grafts may complement the novel techniques of creating arteriovenous access. Finally, innovative solutions to treat stenosed and occluded thoracic central veins can provide an approach to creating a vascular access and allow patients with exhausted vasculature to remain on hemodialysis. The robust developments in hemodialysis vascular access are likely to change practice patterns in the near future.
引用
- Vachharajani TJ, Taliercio JJ, Anvari E, et al. New Devices and Technologies for Hemodialysis Vascular Access: A Review. Am J Kidney Dis. 2021. PMID: 33965296. doi:10.1053/j.ajkd.2020.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。